Category: Leech

citologica
citologica
citologica

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

The 12th Banff Convention on Allograft Pathology was held in Comandatuba, Brazil, from August 19-23, 2013, and was preceded by a 2-day Latin American Symposium on Transplant Immunobiology and Immunopathology. The assembly

citologica
Multiple PDZ domain protein maintains patterning of the apical cytoskeleton in sensory hair cells
Regulation of Neural Circuit Development by Cadherin-11 Provides Implications for Autism
Novel tumour suppressor roles for GZMA and RASGRP1 in Theileria annulata-transformed macrophages and human B-lymphoma cells

Novel tumour suppressor roles for GZMA and RASGRP1 in Theileria annulata-transformed macrophages and human B-lymphoma cellsNovel tumour suppressor roles for GZMA and RASGRP1 in Theileria annulata-transformed macrophages and human B-lymphoma cells

Theileria annulata is a tick-transmitted apicomplexan parasite that infects and transforms bovine leukocytes into disseminating tumours that trigger a illness known as tropical theileriosis. Utilizing comparative transcriptomics we recognized genes

Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironment

Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironmentDual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironment

The dismal final result of hepatocellular carcinoma (HCC) sufferers is attributable to excessive frequency of metastasis and. Identification of efficient biomarkers is a key technique to tell prognosis and enhance

Pevonedistat and azacitidine upregulate NOXA ( PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia

Pevonedistat and azacitidine upregulate NOXA ( PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemiaPevonedistat and azacitidine upregulate NOXA ( PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia

Dysregulation of apoptotic equipment is one mechanism by which acute myeloid leukemia (AML) acquires a clonal survival benefit. B-cell lymphoma protein-2 (BCL2) overexpression is a typical characteristic in hematologic malignancies.